New multiple sclerosis treatment trial compares stem cell transplantation to best available drugs | National Institutes of Health (NIH)
New Clinical Trial Compares Stem Cell Transplantation to Currently Available Drugs for MS | Technology Networks
Israeli study: Stem cells may help multiple sclerosis brain 'repair itself' | The Times of Israel
Multiple Sclerosis and Stem Cell Treatments
Trends in mesenchymal stem cell clinical trials 2004‐2018: Is efficacy optimal in a narrow dose range? - Kabat - 2020 - STEM CELLS Translational Medicine - Wiley Online Library
Small Preliminary Study Examines Blood Stem Cell Transplant to Delay MS Progression - For The Media - JAMA Network
Stem cell therapy for multiple sclerosis: Explanation and safety
Intravascular Mesenchymal Stromal/Stem Cell Therapy Product Diversification: Time for New Clinical Guidelines: Trends in Molecular Medicine
NG-01 Stem Cell Therapy for MS Shows Neuroprotective Effects in Trial
The Clinical Trial that MS Patients Have Been Waiting For
Stem cell therapy may stop and reverse MS, but risks remain | by Sparrow | Sparrow.science | Medium
MS Trial Compares Stem Cell Treatment to Available Therapies
Stem Cell Therapy, A New Multiple Sclerosis Breakthrough in 2022?
HSCT | Multiple Sclerosis Society UK
Shattering barriers toward clinically meaningful MSC therapies
Human mesenchymal stem cells (MSCs) for treatment towards immune- and inflammation-mediated diseases: review of current clinical trials | Journal of Biomedical Science | Full Text
Mesenchymal stem cells for the treatment of multiple sclerosis and other neurological diseases - The Lancet Neurology
Clinical trials using mesenchymal stem cells in MS patients | Download Scientific Diagram
Stem cell therapy for MS
FDA Gives Green Light for Multiple Sclerosis Stem Cell Trial | Business Wire
Global trends in clinical trials involving pluripotent stem cells: a systematic multi-database analysis | npj Regenerative Medicine
Clinical trials using adult stem cells to treat MS (video) - cleveland.com
